Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,285 total articles
Michael Simanovsky, a director and substantial shareholder in Sonida Senior Living, Inc. (NASDAQ:SNDA), alongside Conversant Capital LLC, recently executed a series of common stock sales totaling approximately 4.76 million. The divestitures, conducted on August 28 and September 1, 2026, involved 123,988 shares traded between 38.00 and 39.31 per sha…
CrowdStrike Holdings Inc. (NASDAQ: CRWD) registered a targeted insider transaction on August 28, 2026, when President and Chief Executive Officer George Kurtz sold 200 shares of Class A common stock. The divestment, executed through a pre-arranged 10b5-1 trading protocol established on January 6, 2026, totaled $45,167. Shares were offloaded at pric…
Nuo Therapeutics Inc. leadership has executed additional open market purchases, reflecting continued executive engagement with the company's equity structure. David Emerson Jorden, serving as both chief executive officer and chief financial officer, recently expanded his direct beneficial ownership through two separate transactions. The acquisition…
Nicholas S. Schorsch, a director and ten percent shareholder of American Strategic Investment Co., has increased his equity stake through targeted open-market purchases totaling $67,450. The transactions were executed across two consecutive days in late August 2026 while the stock traded at significantly depressed valuation multiples.
NVE Corp director Daniel A. Baker recently executed a series of equity sales totaling $623,217, reducing his direct stake while the company reports accelerated financial growth and a sharp run-up in share valuation. The transactions unfold as NVEC navigates strong gross margins and rapid revenue expansion, though current pricing metrics suggest pot…
Edwards Lifesciences reported a $113,416 insider share sale by its JAPAC Corporate Vice President, while the company simultaneously delivered strong second-quarter financial results, raised full-year guidance, and received multiple analyst upgrades driven by robust production output and TAVR revenue momentum.
Executive equity acquisition signals internal positioning amid recent operational adjustments and earnings misses. Second-quarter financial results diverged from consensus forecasts, prompting the strategic withdrawal of full-year revenue guidance. Margin expansion and unit volume growth in core segments contrast sharply with significant declines i…
GEO Group Senior Vice President Matthew Albence executed a $316,860 stock sale on August 20, 2026, following a period of significant equity appreciation. The transaction occurs against a backdrop of robust second-quarter earnings, raised full-year guidance, and institutional analyst upgrades, though fair value metrics suggest the current share pric…
Heartflow Inc. (HTFL) Chief Executive Officer John C.M. Farquhar executed a structured equity sale totaling $607,773 in mid-August 2026. The transaction occurred against a backdrop of accelerating financial performance, with the company reporting a 48% year-over-year revenue increase and a narrowed adjusted loss per share. Following the divestment,…
Bloom Energy Corp Chief Commercial Officer Aman Joshi recently sold 4,677 shares for approximately $1.13 million to satisfy tax withholding requirements on restricted stock units. The transaction, executed under a prearranged 10b5-1 plan, occurs as the company reports record second quarter revenue and adjusted EBITDA that significantly exceed Wall …
Pacific Biosciences of California, Inc. (NASDAQ:PACB) President and CEO Mark Van Oene executed an automatic share sale to satisfy tax withholding obligations on August 17, 2026. The transaction occurs as the company navigates a subdued valuation environment, recently reported quarterly revenue that fell short of consensus estimates, and a downward …
Stoke Therapeutics disclosed a mandatory equity liquidation by director Edward M. Kaye MD, executed to satisfy tax withholding requirements on vesting restricted stock units. The transaction aligns with standard compensation protocols while the company advances its lead Dravet syndrome program toward a 2027 regulatory submission and 2028 commercial…
Cisco Systems executive Deborah Stahlkopf liquidated a portion of her equity stake under a Rule 10b5-1 plan, while the company posted fourth-quarter fiscal 2026 results that exceeded consensus estimates. Multiple research desks upgraded price targets, citing accelerating hyperscale demand and sustained artificial intelligence infrastructure spendin…
Sonoco Products Co. leadership reported a significant insider transaction following a robust second-quarter earnings release. The CEO’s recent acquisition underscores executive confidence as the packaging and industrial materials producer navigates inflationary headwinds and freight volatility. Improved working capital metrics and sustained cash ge…
Brent Guerisoli, chief executive officer of Pennant Group, Inc. (NASDAQ:PNTG), completed a $165,066 share sale on August 6, 2026, executing 4,285 shares at $38.522 per share under a Rule 10b5-1 framework established in May 2024. The transaction occurs against a backdrop of accelerated second-quarter 2026 financial results, including adjusted earnin…
BancFirst Corp. director and 10 percent shareholder David Rainbolt liquidated $978,190 in common equity on August 13, 2026, while the institution reports stronger second-quarter margins, a consistent dividend history, and a pending regional acquisition. Market analysts are recalibrating price targets following the operational update and strategic e…
PERDOCEO EDUCATION Corp Chairman Gregory L. Jackson sold 11,271 shares at a weighted average price of $31.78 on August 11, 2026, following the exercise of non-qualified options acquired at $9.69 per share. The transaction occurs as the company posts Q2 2026 earnings of $0.75 per share, surpasses revenue guidance, and announces a dividend increase, …
Senior Vice President Jonathan Mayle of The Honest Company sold 79,000 shares for $412,380 on August 10, 2026, while retaining a substantial equity position. The transaction occurs as the company reports record second-quarter margins, raises full-year revenue and EBITDA forecasts, and receives a Buy rating upgrade from Freedom Broker. Independent v…
Bed Bath & Beyond, Inc. (NASDAQ: BBBY) continues to navigate a pivotal restructuring phase, underscored by fresh insider capital allocation and evolving operational metrics. On August 5, 2026, Executive Chairman and Chief Executive Officer Marcus Lemonis executed a targeted purchase of company equity, signaling continued leadership alignment with t…
Vikas Bhalla, president of ExlService Holdings, Inc., sold 11,000 shares at $34.99 per share on August 3, 2026, generating approximately $384,890 in proceeds. The transaction was executed through a 10b5-1 trading plan established on March 4, 2026, leaving Bhalla with 130,295 directly held shares. The sale occurs as the company reports second-quarte…
Arcutis Biotherapeutics disclosed a routine equity divestment by its Executive Vice President and Chief Medical Officer, executed to cover tax withholding on vested restricted stock units. The transaction coincides with a period of accelerated financial performance, as the company recently reported a significant second-quarter revenue beat and offi…
Hanover Bancorp President Kevin M. O’Connor recently acquired 10,000 shares valued at $268,800, expanding his beneficial ownership to 12,300 shares. The transaction follows a formal leadership appointment effective July 27, 2026, as the company integrates seasoned management to navigate current market conditions. The stock currently trades near its…
Susan Bobulsky, Chief Commercial Officer for Minimal Residual Disease at Adaptive Biotechnologies Corp, recently divested a portion of her equity position through a prearranged trading mechanism. The transaction occurs against a backdrop of significant stock appreciation, mixed quarterly earnings, and upward price target revisions from multiple ins…
Amalgamated Financial Corp. (NASDAQ: AMAL) saw an executive transaction on July 30, 2026, as Director Maryann Bruce sold 2,138 shares for a total of $105,942. The sale occurs alongside a strong second-quarter earnings report that beat analyst expectations and a stock price that has appreciated significantly over the past year.
Robert Joseph Deshaies, chief operating officer for benefits at WEX Inc. (NASDAQ: WEX), sold 1,000 shares of company common stock on July 30, 2026, realizing $184,950 in total proceeds. The transaction took place at a share price between $184.92 and $185.00. Deshaies retains direct ownership of 19,288 shares following the sale. The insider activity…
